Hosted on MSN

TNXP stock rises premarket: Investors cheer early traction for fibromyalgia drug despite weak Q4 print

・CEO Seth Lederman said early trends show favorable prescriber uptake and repeat utilization. ・Investors are also watching TNX-4800, with the company planning FDA talks on Phase 2/3 development and ...
Hosted on MSN

TNXP stock dives for four straight sessions — retail eyes drug pipeline payoff

・Tonix is now evaluating its Tonmya drug for the treatment of major depressive disorder and acute stress disorder/acute stress reaction. ・The company also expects to initiate a U.S. field study in ...